ArticleActa neurologica Belgica2018

Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus.

Ben Sprangers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.